Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.
Richard B LiptonJoshua M CohenMaja GalicMichael J SeminerioPaul P YeungErnesto AycardiMarcelo E BigalKristen BibeauDawn C BusePublished in: Headache (2021)
Fremanezumab demonstrated efficacy in the preventive treatment of CM and reduced headache impact in patients with comorbid depression.